SciELO - Scientific Electronic Library Online

 
vol.66 número2Enfermedad granulomatosa crónica. Actualización y revisiónReacción alérgica tardía a furosemida con positividad de la prueba de transformación de linfocitos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista alergia México

versión On-line ISSN 2448-9190

Resumen

ZURITA-CRUZ,, Jessie Nallely; BARBOSA-CORTES,, Lourdes  y  VILLASIS-KEEVER, Miguel Ángel. From research to practice: clinical phases for drug development. Rev. alerg. Méx. [online]. 2019, vol.66, n.2, pp.246-253. ISSN 2448-9190.  http://dx.doi.org/10.29262/ram.v66i2.625.

Clinical trials become very relevant in the development of new drugs when their pharmacokinetics, pharmacodynamics, efficiency, safety and possible adverse effects are being assessed. So new drugs are available for their daily use in patients, a model has been proposed for more than four decades; This model consists in the realization of sequential research studies, which were called clinical phases I, II, III and IV, which begin once the drugs’ effects have been verified in cellular and animal models (preclinical phase). In this article, the general characteristics of each of the clinical phases are synthesized but, apart from that, the modifications that have been done over the years are described with the purpose of making new drugs available in a quicker way.

Palabras llave : Clinical research; Clinical trials; Drug design.

        · resumen en Español     · texto en Español     · Español ( pdf )